X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3675) 3675
Newspaper Article (186) 186
Book Chapter (80) 80
Book / eBook (12) 12
Web Resource (4) 4
Trade Publication Article (3) 3
Conference Proceeding (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2888) 2888
life sciences & biomedicine (2731) 2731
neurotoxicity (2429) 2429
humans (2178) 2178
animals (1341) 1341
male (1328) 1328
female (1071) 1071
neurotoxicity syndromes - etiology (1054) 1054
neurosciences & neurology (941) 941
neurosciences (839) 839
middle aged (585) 585
adult (584) 584
oncology (552) 552
pharmacology & pharmacy (540) 540
rats (521) 521
neurotoxicity syndromes - drug therapy (494) 494
chemotherapy (491) 491
aged (390) 390
cancer (390) 390
neurology (388) 388
clinical neurology (385) 385
mice (380) 380
brain (379) 379
toxicology (355) 355
health aspects (339) 339
neurotoxicity syndromes - pathology (322) 322
toxicity (322) 322
disease models, animal (321) 321
risk factors (319) 319
oxidative stress (317) 317
apoptosis (309) 309
research (305) 305
nervous system (302) 302
neurotoxicity syndromes - physiopathology (298) 298
proteins (298) 298
analysis (297) 297
patients (295) 295
care and treatment (286) 286
neurotoxicity syndromes - diagnosis (280) 280
neurons (272) 272
neurons - drug effects (266) 266
antineoplastic agents - adverse effects (265) 265
neuroprotection (264) 264
neurodegeneration (260) 260
dose-response relationship, drug (257) 257
neurotoxicity syndromes - prevention & control (257) 257
inflammation (255) 255
rodents (255) 255
medicine (252) 252
neurodegenerative diseases (249) 249
brain - drug effects (246) 246
cytokines (244) 244
medicine & public health (237) 237
drug therapy (236) 236
neuroprotective agents - pharmacology (235) 235
neurotoxicity syndromes - metabolism (235) 235
biochemistry & molecular biology (228) 228
drug dosages (227) 227
cell biology (224) 224
pediatrics (223) 223
treatment outcome (223) 223
child (219) 219
adolescent (216) 216
alzheimer's disease (210) 210
biomedicine (210) 210
rats, sprague-dawley (205) 205
neurotoxicity syndromes (203) 203
complications and side effects (202) 202
clinical trials (200) 200
magnetic resonance imaging (200) 200
studies (200) 200
research article (198) 198
hematology (196) 196
review (196) 196
psychiatry (192) 192
cancer therapies (191) 191
peripheral nervous system diseases - chemically induced (185) 185
brain - pathology (180) 180
oxidative stress - drug effects (172) 172
peripheral neuropathy (172) 172
neurons - metabolism (171) 171
encephalopathy (170) 170
parkinson's disease (170) 170
rats, wistar (165) 165
central nervous system (164) 164
metabolism (161) 161
neurotoxicity syndromes - therapy (160) 160
dopamine (158) 158
science & technology - other topics (156) 156
medical research (153) 153
neuropathy (153) 153
leukemia (152) 152
multidisciplinary sciences (152) 152
nervous system diseases (152) 152
pain (152) 152
neuroprotective agents - therapeutic use (151) 151
gene expression (149) 149
kinases (149) 149
time factors (148) 148
cells, cultured (147) 147
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3895) 3895
German (30) 30
Japanese (22) 22
Russian (21) 21
French (18) 18
Spanish (16) 16
Portuguese (7) 7
Chinese (5) 5
Polish (4) 4
Danish (3) 3
Dutch (2) 2
Serbian (2) 2
Arabic (1) 1
Italian (1) 1
Korean (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer discovery, ISSN 2159-8290, 08/2018, Volume 8, Issue 8, pp. 958 - 971
Journal Article
Journal of controlled release, ISSN 0168-3659, 12/2018, Volume 292, pp. 183 - 195
Journal Article
Neuropharmacology, ISSN 0028-3908, 06/2014, Volume 81, pp. 142 - 152
Journal Article
Neuroscience, ISSN 0306-4522, 2015, Volume 313, pp. 162 - 173
Journal Article
PloS one, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, pp. e0128080 - e0128080
Neurotoxicity is a main side effect of the anticancer drug oxaliplatin. The development of a neuropathic syndrome impairs quality of life and potentially results in chemotherapy dose reductions and/or early discontinuation... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Ethanolamines - pharmacology | Neurons - pathology | Neuralgia - complications | Neuroglia - pathology | Humans | Palmitic Acids - therapeutic use | Male | Neurotoxicity Syndromes - drug therapy | Neuroglia - drug effects | Oxaliplatin | Nervous System - pathology | Neurotoxicity Syndromes - pathology | Inflammation Mediators - metabolism | Behavior, Animal - drug effects | Neurons - metabolism | Palmitic Acids - pharmacology | Neurons - drug effects | Disease Models, Animal | Neurotoxicity Syndromes - complications | Activating Transcription Factor 3 - metabolism | Rats, Sprague-Dawley | Neuralgia - drug therapy | HT29 Cells | Animals | Nervous System - drug effects | Ganglia, Spinal - pathology | Ethanolamines - therapeutic use | Neuroglia - metabolism | Ganglia, Spinal - drug effects | Organoplatinum Compounds - adverse effects | Development and progression | Research | Peripheral nerve diseases | Risk factors | Oxidative stress | Neuroprotection | Spinal cord | Heat treatment | Neurosciences | Animal models | Childrens health | Peripheral nerves | Nervous system | Diabetic neuropathy | Activation | Neuropathy | Glial cells | Peripheral neuropathy | Experiments | Cancer therapies | Neuronal-glial interactions | Anticancer properties | Neurotoxicity | Toxicology | Pain | Colon cancer | Dorsal root ganglia | Rodents | Nerves | Colon | Thermal stimuli | Drug dosages | Hypertension | Pain perception | Pharmacology | Fatty acids | Ganglia | Molecular chains | Quality of life | Medicine | Chemotherapy | Side effects | Environmental science | Morphology | Laboratory animals | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 670 - 678
...%. A clear understanding of the acute complications and late effects of osteosarcoma therapy is required to care effectively for patients with osteosarcoma undergoing active treatment, and for the... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Osteosarcoma - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Heart Diseases - prevention & control | Cisplatin - administration & dosage | Neoplasms, Second Primary - chemically induced | Kidney Diseases - chemically induced | Bone Neoplasms - drug therapy | Heart Diseases - chemically induced | Hearing Loss - chemically induced | Doxorubicin - administration & dosage | Antidotes | Kidney Diseases - prevention & control | Infertility - prevention & control | Ifosfamide - adverse effects | Survivors | Neurotoxicity Syndromes - prevention & control | Neoplasms, Second Primary - prevention & control | Neurotoxicity Syndromes - etiology | Methotrexate - adverse effects | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Methotrexate - administration & dosage | Doxorubicin - adverse effects | Hearing Loss - prevention & control | Infertility - chemically induced | Osteosarcoma | Chemotherapy | Cancer | Index Medicus | Heart | Complications | Ifosfamide | Etoposide | Cytotoxicity | Drug development | Doxorubicin | Survival | Cisplatin | Hearing loss | Neurotoxicity | Infertility | Methotrexate | Acute toxicity
Journal Article